Cargando…

Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial

BACKGROUND: Although remote ischaemic preconditioning (RIP) provides protection against myocardial ischaemia and reperfusion injury during cardiac surgery, it is not widely used. Systemic intermittent hypoxic–hyperoxic training (IHHT) may be a suitable alternative. METHODS: This is a prospective, si...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuter, Denis S, Kopylov, Philippe Y, Syrkin, Abram L, Glazachev, Oleg S, Komarov, Roman N, Katkov, Andrei I, Severova, Ljudmila P, Ivanova, Ekaterina V, Zhang, Young, Saner, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241980/
https://www.ncbi.nlm.nih.gov/pubmed/30487981
http://dx.doi.org/10.1136/openhrt-2018-000891
_version_ 1783371802684162048
author Tuter, Denis S
Kopylov, Philippe Y
Syrkin, Abram L
Glazachev, Oleg S
Komarov, Roman N
Katkov, Andrei I
Severova, Ljudmila P
Ivanova, Ekaterina V
Zhang, Young
Saner, Hugo
author_facet Tuter, Denis S
Kopylov, Philippe Y
Syrkin, Abram L
Glazachev, Oleg S
Komarov, Roman N
Katkov, Andrei I
Severova, Ljudmila P
Ivanova, Ekaterina V
Zhang, Young
Saner, Hugo
author_sort Tuter, Denis S
collection PubMed
description BACKGROUND: Although remote ischaemic preconditioning (RIP) provides protection against myocardial ischaemia and reperfusion injury during cardiac surgery, it is not widely used. Systemic intermittent hypoxic–hyperoxic training (IHHT) may be a suitable alternative. METHODS: This is a prospective, single-centre, randomised controlled trial. 127 patients with ischaemic heart disease and indication for coronary artery bypass graft (CABG) surgery from the Cardiology Clinic IM Sechenov First Moscow State Medical University were randomly assigned to IHHT, IHHT-control or RIP. Primary endpoint was serum concentration of troponin I and lactate 2 and 24 hours after surgery. RESULTS: Median value for troponin I 24 hours after surgery was 1.068 (0.388–1.397) ng/mL in the IHHT group and was significantly lower compared with IHHT-controls with 1.980 (1.068–3.239) ng/mL (p=0.012) and to the RIP group with 1.762 (1.288–2.186) ng/mL (p=0.029), while there was no significant difference between RIP and the IHHT-control. Serum lactate after surgery was 1.74 (1.23–2.04) mmol/L in the IHHT group and was also significantly lower compared with IHHT-controls with 2.10 (1.80–2.29) mmol/L (p=0.045) and RIP with 2.12 (1.91–2.33) mmol/L (p=0.032). No significant complications or serious adverse events were observed during IHHT. Intraoperative and early postoperative complications did not differ significantly between groups. CONCLUSIONS: The results of this first trial using IHHT for myocardial protection against perioperative ischaemic myocardial injury in patients undergoing CABG surgery are promising and further larger trials should be done with adequate power to detect clinical rather than surrogate marker benefits.
format Online
Article
Text
id pubmed-6241980
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-62419802018-11-28 Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial Tuter, Denis S Kopylov, Philippe Y Syrkin, Abram L Glazachev, Oleg S Komarov, Roman N Katkov, Andrei I Severova, Ljudmila P Ivanova, Ekaterina V Zhang, Young Saner, Hugo Open Heart Basic and Translational Research BACKGROUND: Although remote ischaemic preconditioning (RIP) provides protection against myocardial ischaemia and reperfusion injury during cardiac surgery, it is not widely used. Systemic intermittent hypoxic–hyperoxic training (IHHT) may be a suitable alternative. METHODS: This is a prospective, single-centre, randomised controlled trial. 127 patients with ischaemic heart disease and indication for coronary artery bypass graft (CABG) surgery from the Cardiology Clinic IM Sechenov First Moscow State Medical University were randomly assigned to IHHT, IHHT-control or RIP. Primary endpoint was serum concentration of troponin I and lactate 2 and 24 hours after surgery. RESULTS: Median value for troponin I 24 hours after surgery was 1.068 (0.388–1.397) ng/mL in the IHHT group and was significantly lower compared with IHHT-controls with 1.980 (1.068–3.239) ng/mL (p=0.012) and to the RIP group with 1.762 (1.288–2.186) ng/mL (p=0.029), while there was no significant difference between RIP and the IHHT-control. Serum lactate after surgery was 1.74 (1.23–2.04) mmol/L in the IHHT group and was also significantly lower compared with IHHT-controls with 2.10 (1.80–2.29) mmol/L (p=0.045) and RIP with 2.12 (1.91–2.33) mmol/L (p=0.032). No significant complications or serious adverse events were observed during IHHT. Intraoperative and early postoperative complications did not differ significantly between groups. CONCLUSIONS: The results of this first trial using IHHT for myocardial protection against perioperative ischaemic myocardial injury in patients undergoing CABG surgery are promising and further larger trials should be done with adequate power to detect clinical rather than surrogate marker benefits. BMJ Publishing Group 2018-11-10 /pmc/articles/PMC6241980/ /pubmed/30487981 http://dx.doi.org/10.1136/openhrt-2018-000891 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Basic and Translational Research
Tuter, Denis S
Kopylov, Philippe Y
Syrkin, Abram L
Glazachev, Oleg S
Komarov, Roman N
Katkov, Andrei I
Severova, Ljudmila P
Ivanova, Ekaterina V
Zhang, Young
Saner, Hugo
Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial
title Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial
title_full Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial
title_fullStr Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial
title_full_unstemmed Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial
title_short Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial
title_sort intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial
topic Basic and Translational Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241980/
https://www.ncbi.nlm.nih.gov/pubmed/30487981
http://dx.doi.org/10.1136/openhrt-2018-000891
work_keys_str_mv AT tuterdeniss intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial
AT kopylovphilippey intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial
AT syrkinabraml intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial
AT glazachevolegs intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial
AT komarovromann intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial
AT katkovandreii intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial
AT severovaljudmilap intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial
AT ivanovaekaterinav intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial
AT zhangyoung intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial
AT sanerhugo intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial